Display options
Cite
Contreras-Zárate MJ, Ormond DR, Gillen AE, et al. Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases. Front Oncol. 2017;7:252doi: 10.3389/fonc.2017.00252.
Contreras-Zárate, M. J., Ormond, D. R., Gillen, A. E., Hanna, C., Day, N. L., Serkova, N. J., Jacobsen, B. M., Edgerton, S. M., Thor, A. D., Borges, V. F., Lillehei, K. O., Graner, M. W., Kabos, P., & Cittelly, D. M. (2017). Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases. Frontiers in oncology, 7252. https://doi.org/10.3389/fonc.2017.00252
Contreras-Zárate, María J, et al. "Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases." Frontiers in oncology vol. 7 (2017): 252. doi: https://doi.org/10.3389/fonc.2017.00252
Contreras-Zárate MJ, Ormond DR, Gillen AE, Hanna C, Day NL, Serkova NJ, Jacobsen BM, Edgerton SM, Thor AD, Borges VF, Lillehei KO, Graner MW, Kabos P, Cittelly DM. Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases. Front Oncol. 2017 Nov 02;7:252. doi: 10.3389/fonc.2017.00252. eCollection 2017. PMID: 29164052; PMCID: PMC5673842.
Copy Download .nbib Format: NLM
Share it on

Front Oncol. 2017 Nov 02;7:252. doi: 10.3389/fonc.2017.00252. eCollection 2017.

Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.

Frontiers in oncology

María J Contreras-Zárate, D Ryan Ormond, Austin E Gillen, Colton Hanna, Nicole L Day, Natalie J Serkova, Britta M Jacobsen, Susan M Edgerton, Ann D Thor, Virginia F Borges, Kevin O Lillehei, Michael W Graner, Peter Kabos, Diana M Cittelly

Affiliations

  1. Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  2. Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  3. RNA Bioscience Initiative, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  4. Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  5. Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

PMID: 29164052 PMCID: PMC5673842 DOI: 10.3389/fonc.2017.00252

Abstract

Brain metastases are an increasing burden among breast cancer patients, particularly for those with HER2

Keywords: HER2+; brain colonization; brain metastases models; breast cancer; patient-derived xenograft; triple negative

References

  1. Nat Med. 2011 Oct 23;17(11):1514-20 - PubMed
  2. Nat Rev Cancer. 2011 Feb;11(2):135-41 - PubMed
  3. Cancer Res. 2013 Sep 15;73(18):5764-74 - PubMed
  4. Breast Cancer Res. 2014 Apr 07;16(2):R36 - PubMed
  5. J Mol Cell Biol. 2009 Oct;1(1):3-5 - PubMed
  6. Breast Dis. 2006-2007;26:139-47 - PubMed
  7. Neoplasma. 2013;60(3):290-4 - PubMed
  8. Clin Oncol (R Coll Radiol). 2004 Aug;16(5):345-9 - PubMed
  9. Biochem Pharmacol. 2014 Sep 15;91(2):135-43 - PubMed
  10. Nature. 2009 Jun 18;459(7249):1005-9 - PubMed
  11. Nat Med. 2016 Jul;22(7):723-6 - PubMed
  12. Cancer Res. 2006 Apr 1;66(7):3386-91 - PubMed
  13. Curr Protoc Pharmacol. 2012 Dec;Chapter 14:Unit 14.22 - PubMed
  14. Am J Pathol. 2013 Oct;183(4):1084-1095 - PubMed
  15. Cancer Res. 2007 May 1;67(9):4190-8 - PubMed
  16. Cancer Res. 2007 Feb 15;67(4):1472-86 - PubMed
  17. Genome Biol. 2014;15(12):550 - PubMed
  18. Cancer Res. 2005 Nov 1;65(21):9779-88 - PubMed
  19. J Vis Exp. 2017 Feb 8;(120): - PubMed
  20. Breast Cancer Res. 2011 Sep 13;13(5):R87 - PubMed
  21. Am J Pathol. 2005 Oct;167(4):913-20 - PubMed
  22. Nucleic Acids Res. 2013 May 1;41(10):e108 - PubMed
  23. Am J Surg Pathol. 2006 Sep;30(9):1097-104 - PubMed
  24. Breast Cancer Res Treat. 2012 Sep;135(2):415-32 - PubMed
  25. J Vis Exp. 2016 Nov 30;(117): - PubMed
  26. Nat Rev Clin Oncol. 2011 Jun;8(6):344-56 - PubMed
  27. Neuropathol Appl Neurobiol. 2011 Feb;37(2):189-205 - PubMed
  28. Med Mol Morphol. 2011 Mar;44(1):15-20 - PubMed
  29. Cell. 2011 Oct 14;147(2):275-92 - PubMed
  30. Breast Cancer Res. 2015 Jan 09;17:3 - PubMed
  31. Nat Rev Clin Oncol. 2012 Apr 17;9(6):338-50 - PubMed
  32. JAMA Oncol. 2017 May 1;3(5):666-671 - PubMed
  33. Cancer Res. 2013 Sep 1;73(17):5315-9 - PubMed
  34. J Clin Oncol. 2004 Sep 1;22(17):3608-17 - PubMed
  35. Crit Rev Oncol Hematol. 2010 Aug;75(2):110-21 - PubMed
  36. Cancer Metastasis Rev. 2016 Dec;35(4):547-573 - PubMed
  37. Oncogene. 2013 May 16;32(20):2555-64 - PubMed
  38. Genome Biol. 2013 Apr 25;14(4):R36 - PubMed
  39. Breast J. 2012 Jul-Aug;18(4):345-50 - PubMed
  40. Breast. 2013 Oct;22(5):993-8 - PubMed
  41. Nat Cell Biol. 2013 Jul;15(7):807-17 - PubMed
  42. Oncology (Williston Park). 2008 Oct;22(11):1233-9; discussion 1239-40, 1243 - PubMed
  43. Clin Cancer Res. 2015 Mar 1;21(5):1172-82 - PubMed
  44. Cancer. 2006 Aug 15;107(4):696-704 - PubMed
  45. Lancet Neurol. 2005 May;4(5):289-98 - PubMed
  46. PLoS One. 2014 Feb 24;9(2):e89389 - PubMed
  47. F1000Res. 2016 Nov 22;5:2741 - PubMed

Publication Types

Grant support